Clinical Trial Update: Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on maintenance treatment with toripalimab (JS001) in unresectable locally advanced or metastatic mucosal melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Mucosal Melanoma | Phase 2 | Status: UNKNOWN